Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 1Leukemia, Myelomonocytic, Chronic 1

Interventions

Peripheral Blood Stem Cell Transplantation 4Azacitidine 4fludarabine phosphate 2Lenalidomide 2Decitabine 2Cytarabine 2Cyclophosphamide 2treosulfan 1sargramostim 1eprenetapopt 1aldesleukin 1Whole-Body Irradiation 1Therapeutics 1Tacrolimus 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Levofloxacin 1Ketamine 1Idarubicin 1Histamine 1Flow Cytometry 1Filgrastim 1Etoposide 1Cefepime 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myelomonocytic, Chronic × eprenetapopt × Clear all
NCT03588078 2020-01-30

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Groupe Francophone des Myelodysplasies

Phase 1/2 Unknown
53 enrolled
MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡